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Abstract. 
 
Listeria monocytogenes
 
 is a facultative intra-
cellular bacterial pathogen that spreads cell to cell with-
out exposure to the extracellular environment. Bacte-
rial cell-to-cell spread is mediated in part by two 
secreted bacterial phospholipases C (PLC), a broad 
spectrum PLC (PC-PLC) and a phosphatidylinositol-
specific PLC (PI-PLC). PI-PLC is secreted in an active 
state, whereas PC-PLC is secreted as an inactive proen-
zyme (proPC-PLC) whose activation is mediated in 
vitro by an 
 
L. monocytogenes
 
 metalloprotease (Mpl). 
Analysis of PI-PLC, PC-PLC, and Mpl single and dou-
ble mutants revealed that Mpl also plays a role in the 
spread of an infection, but suggested that proPC-PLC 
has an Mpl-independent activation pathway. Using bio-
chemical and microscopic approaches, we describe 
three intracellular proteolytic pathways regulating PC-
PLC activity. Initially, proPC-PLC secreted in the cyto-
sol of infected cells was rapidly degraded in a protea-
some-dependent manner. Later during infection, PC-
PLC colocalized with bacteria in lysosome-associated 
membrane protein 1–positive vacuoles. Activation of 
proPC-PLC in vacuoles was mediated by Mpl and an 
Mpl-independent pathway, the latter being sensitive to 
inhibitors of cysteine proteases. Lastly, proPC-PLC ac-
tivation by either pathway was sensitive to bafilomycin 
A
 
1
 
, a specific inhibitor of vacuolar ATPase, suggesting 
that activation was dependent on acidification of the 
vacuolar compartment. These results are consistent 
with a model in which proPC-PLC activation is com-
partment specific and controlled by a combination of 
bacterial and host factors.
 
L
 
isteria
 
 
 
monocytogenes
 
 is a facultative intracellular
bacterial pathogen that infects a variety of mamma-
lian cells both in vivo and in vitro (Cossart and
Mengaud, 1989; Gaillard et al., 1987; Havell, 1986; Kuhn
et al., 1988; Portnoy et al., 1988). Microscopic studies of
the intracellular growth cycle of 
 
L. monocytogenes
 
 have
revealed a fascinating relationship between this microbe
and its host (Mounier et al., 1990; Tilney and Portnoy,
1989). Subsequent to internalization, the bacterium medi-
ates lysis of the surrounding vacuolar membrane and ini-
tiates rapid intracytosolic multiplication. Asymmetric poly-
merization of host actin at the bacterial surface results in
actin-based motility and formation of filopodia-like struc-
tures that facilitate direct bacterial cell-to-cell spread (Da-
biri et al., 1990; Mounier et al., 1990; Theriot et al., 1992;
Tilney and Portnoy, 1989). During cell-to-cell spread,
bacteria become transiently confined in secondary vacu-
oles, which are presumably formed upon phagocytosis of
filopodia-like structures (Mounier et al., 1990; Tilney and
Portnoy, 1989). Lastly, lysis of secondary vacuoles results
in continuation of the intracellular cycle. This strategy of
cell-to-cell spread facilitates propagation of the bacterial
infection without exposure to the host’s humoral immune
response. A similar strategy has been adapted by a num-
ber of other microbial pathogens including 
 
Shigellae
 
 (Ber-
nardini et al., 1989)
 
, Rickettsiae
 
 (Heinzen et al., 1993; Teys-
seire et al., 1992), and Vaccinia virus (Cudmore et al.,
1995).
The primary virulence factors of 
 
L. monocytogenes
 
 have
been identified (Portnoy et al., 1992). Lysis of the primary
vacuole, formed upon initial phagocytosis, is largely medi-
ated by a secreted pore-forming hemolysin called listerio-
lysin O (LLO)
 
1
 
 (Bielecki et al., 1990; Gaillard et al., 1987;
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1. 
 
Abbreviations used in this paper
 
: BHI, brain heart infusion broth; CFU,
colony forming unit; Lamp1, lysosome-associated membrane protein 1;
LD
 
50
 
, 50% lethal dose; LLM, 
 
N
 
-acetyl-leucine-leucine-methionine; LLnL,
 
N
 
-acetyl-leucine-leucine-norleucine; LLO, listeriolysin O; Mpl, 
 
Listeria
monocytogenes
 
 metalloprotease; PC, phosphatidylcholine; PLC, phospho-
lipase C; PC-PLC, broad-range PLC; PI-PLC, phosphatidylinositol-spe-
cific PLC; proPC-PLC, secreted proenzyme form of PC-PLC.
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Tilney and Portnoy, 1989). Nonhemolytic mutants of 
 
L.
monocytogenes
 
 are unable to grow intracellularly in most
cell types (Gaillard et al., 1987; Portnoy et al., 1988) and
are completely avirulent in mice (Cossart et al., 1989; Gail-
lard et al., 1986; Kathariou et al., 1987; Michel et al., 1990;
Portnoy et al., 1988). Escape from the primary vacuole is
also enhanced by two secreted bacterial phospholipases C
(PLC): a phosphatidylinositol-specific PLC (PI-PLC)
(Camilli et al., 1993) and a broad-range PLC (PC-PLC)
(Marquis et al., 1995; Smith et al., 1995). The ability to
spread depends on the 
 
L. monocytogenes
 
 ActA protein
that mediates actin polymerization (Brundage et al., 1993;
Domann et al., 1992; Kocks et al., 1992). ActA mutants are
able to escape from the primary vacuole, but they are un-
able to spread within cells or cell to cell. Bacterial factors
mediating escape from the secondary vacuole formed dur-
ing cell-to-cell spread are not as well defined as those for
escape from the primary vacuole. The role of LLO in bac-
terial cell-to-cell spread has been difficult to address as
nonhemolytic mutants fail to gain access to the cytosol
(Gaillard et al., 1987; Tilney and Portnoy, 1989). However,
the two PLCs are clearly important as mutants lacking ei-
ther PC-PLC or both PLCs form small plaques in murine
fibroblasts, presumably because they are less efficient in
escaping from secondary vacuoles (Smith et al., 1995;
Vazquez-Boland et al., 1992). The precise functions of the
PLCs or their precise sites of action are not clear.
PC-PLC is secreted as an inactive precursor (proPC-
PLC), and proteolytic cleavage at its NH
 
2
 
 terminus gener-
ates the active form of the enzyme (Niebuhr et al., 1993;
Raveneau et al., 1992). In vitro activation of proPC-PLC is
mediated by a secreted bacterial metalloprotease (Mpl)
with homology to members of a family of bacterial zinc-
containing metalloproteases (Poyart et al., 1993; Domann et
al., 1991; Häse and Finkelstein, 1993; Mengaud et al.,
1991). The in vivo role of Mpl has not been determined.
In the present study we have defined the requirements
for the intracellular activation of proPC-PLC. The intra-
cellular activation of proPC-PLC was mediated by two dif-
ferent enzymes: a bacterial metalloprotease (Mpl), which
is also active in vitro, and a cysteine protease, whose activ-
ity could only be detected during intracellular infection.
The relative activity of PC-PLC generated by either pro-
tease on phosphatidylcholine (PC) or sphingomyelin was
essentially the same. Furthermore, proPC-PLC activation
by either pathway was dependent on (
 
a
 
) vacuolar bacterial
localization and (
 
b
 
) vacuolar acidification. In the absence
of bacterial cell-to-cell spread, proPC-PLC was synthe-
sized but not activated. Instead, cytosolic proPC-PLC was
rapidly degraded in a proteasome-dependent manner.
 
Materials and Methods
 
Bacterial Strains and Culture Conditions
 
Bacterial strains and relevant genotypes are listed in Table I. Two wild-
type 
 
L. monocytogenes
 
 strains were used for this study: 10403S (Bishop
and Hinrichs, 1987) and SLCC-5764 (Camilli et al., 1993). For all cell in-
fection assays, strain 10403S and isogenic mutants were used. Strain
SLCC-5764 and isogenic mutants were only used for detection of PC-PLC
in broth culture. All strains were grown in brain heart infusion broth (BHI;
Difco Laboratories, Detroit, MI) and maintained on BHI agar. Stock cul-
tures were stored at 
 
2
 
80
 
8
 
C.
 
Construction of L. monocytogenes Mutant Strains
 
Derivatives of pKSV7 (Smith and Youngman, 1992) were maintained in
 
Escherichia coli
 
 DH5
 
a
 
 (Life Technologies, Grand Island, NY) by growth
in the presence of ampicillin (50 
 
m
 
g/ml). The internal in-frame deletion in
 
mpl
 
 was generated as follows. Two fragments of 
 
mpl
 
 were amplified from
10403S chromosomal DNA by PCR and ligated sequentially into pKSV7.
The 3
 
9
 
 end fragment encompassing bases 3,172–3,767 (Domann et al.,
1991) was ligated into pKSV7 by use of BamHI- and SmaI-generated
DNA ends creating pDP2263. Primers used were 5
 
9
 
-GGCGGGATC-
CGAATACGAA-3
 
9
 
 (primer 2239) and 5
 
9
 
-CCCCCGGGCCTTCTTTT-
TCACTAATT-3
 
9
 
 (primer 1701). The 5
 
9
 
 end fragment encompasses bases
1,857–2,487 (Domann et al., 1991), which was ligated into pDP2263 by use
of SalI- and BamHI-generated DNA ends, creating pDP2264. Primers
used were 5
 
9
 
-GAAGAATGTCGACACAGGCTTA-3
 
9
 
 (primer 1702)
and 5
 
9
 
-GGACCGATGGATCCAAATGCTT-3
 
9
 
 (primer 2238). This re-
sulted in a 
 
D
 
mpl
 
 allele with a 684-bp in-frame deletion (228 amino acids),
encompassing 45% of the open reading frame including the putative
propeptide cleavage site and the putative active site of the protease. The
construct was confirmed by DNA sequence analysis.
Allelic exchange of the 10403S chromosomal 
 
mpl
 
 allele with the 
 
D
 
mpl
 
allele was performed as described previously (Camilli et al., 1993). Strain
DP-L2296 (
 
D
 
mpl
 
) was derived from 
 
L. monocytogenes
 
 10403S. Isogenic
strains DP-L2787 (
 
D
 
plcB
 
, 
 
D
 
mpl
 
), DP-L2483 (
 
D
 
plcA
 
, 
 
D
 
mpl
 
), and DP-
L2869 (
 
D
 
plcA
 
, 
 
D
 
plcB
 
, 
 
D
 
mpl
 
) were derived from 
 
L. monocytogenes
 
 DP-
L1935 (
 
D
 
plcB
 
) (Smith et al., 1995), DP-L1552 (
 
D
 
plcA
 
) (Camilli et al.,
1993), and DP-L1936 (
 
D
 
plcA
 
, 
 
D
 
plcB
 
) (Smith et al., 1995), respectively.
An internal out-of-frame 
 
mpl
 
 deletion was generated in strain SLCC-
5764. The 
 
mpl
 
 gene was digested with BamHI and XbaI, treated with Kle-
now to produce blunt ends, and religated, generating pDP1434. Directly
downstream of the 83-bp deletion were three new codons followed by a
stop codon. The resulting open reading frame was 274 amino acids long,
corresponding to 
 
z
 
50% of the original protein and lacking the putative
active site of the protease. Allelic exchange of the SLCC-5764 chromo-
somal 
 
mpl
 
 allele with the 
 
D
 
mpl
 
 allele was performed as described previ-
ously (Camilli et al., 1993), generating strain DP-L1545. Isogenic strain
DP-L1938 (
 
D
 
plcA
 
, 
 
D
 
plcB
 
) was constructed by transforming DP-L1553
(
 
D
 
plcA
 
) (Camilli et al., 1993) with pDP1888 (
 
D
 
plcB
 
) (Smith et al., 1995),
generating the equivalent of DP-L1936 (Smith et al., 1995), but in an
SLCC-5764 background. Isogenic strain DP-L1955 is the equivalent of
DP-L1942 (Brundage et al., 1993), but in an SLCC-5764 background.
The correct gene deletions on the 
 
L. monocytogenes
 
 chromosome were
confirmed by determining the size of the corresponding chromosomal re-
striction fragment by Southern blotting, and by amplifying the deleted al-
lele using PCR.
 
Complementation of L. monocytogenes 
 
D
 
mpl
Mutant Strains
 
The 
 
L. monocytogenes mpl
 
 gene was amplified from 10403S chromosomal
DNA by PCR and ligated into pKSV7 by use of SalI- and SmaI-generated
DNA ends to generate pDP2437. The primers used were 1701 and 1702
(see above). Allelic exchange was used to replace the 
 
D
 
mpl
 
 allele of strain
DP-L2296 with 10403S 
 
mpl
 
 allele as described (Camilli et al., 1993). Strain
DP-L2484, a wild-type revertant, was identified by PCR amplification of
the 
 
mpl
 
 allele and by Southern blotting. DP-L2484 formed wild-type size
plaques, whereas DP-L2296 formed smaller plaques as reported in the
Results section.
 
SDS-PAGE and Western Immunoblotting
 
Secreted 
 
L. monocytogenes
 
 polypeptides were prepared from strain
SLCC-5764 and isogenic mutants as previously described with minor mod-
ifications (Camilli et al., 1993). After an overnight incubation in BHI
broth, the cultures were diluted 1:10 and incubated at 37
 
8
 
C with shaking
for an additional 5 h. Secreted bacterial polypeptides were precipitated on
ice in 10% TCA and suspended in 2
 
3
 
 SDS-PAGE sample buffer/0.2 N
NaOH, to 1% of the original volume. The secreted polypeptide prepara-
tions were fractionated by electrophoresis on a 10% SDS-polyacrylamide
gel. For Coomassie blue staining, 25 
 
m
 
l of the preparation was loaded per
well (equivalent to 2.5 ml of bacterial culture supernatant), whereas for
the Western immunoblot and egg yolk overlay assay, 10 
 
m
 
l was loaded per
well (equivalent to 1.0 ml of bacterial culture supernatant).
For the Western immunoblot, proteins were electrotransferred to poly-
vinylidene difluoride membrane (Millipore Corp., Bedford, MA) and 
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reacted with affinity-purified anti–PC-PLC rabbit antibodies. Alkaline
phosphatase–labeled affinity-purified goat antibody to rabbit IgG (Kirke-
gaard & Perry Laboratories, Inc., Gaithersburg, MD) was used as second-
ary antibody, and the enzymatic reaction was induced with nitroblue tetra-
zolium and 5-bromo-4-chloro-3-indolyl phosphate (Sigma Chemical Co.,
St. Louis, MO).
 
Plaque Formation and Virulence Assay
 
The plaquing assay was performed as previously described (Sun et al.,
1990). Plaques formed in monolayers of mouse fibroblast L2 cells were vi-
sualized by staining the cells with neutral red at 4 d after infection. The
mean plaque diameter formed by each strain was compared with the mean
plaque diameter of strain 10403S. The relative plaque size is reported as a
percentage of wild-type plaque size. 50% lethal doses (LD
 
50
 
) were deter-
mined in BALB/c mice by intravenous injection of bacteria as described
previously (Portnoy et al., 1988).
 
Infection of J774 Cells and Metabolic Labeling
of PC-PLC
 
J774 mouse macrophage-like cells were propagated in a spinner flask as
described (Brundage et al., 1993). The evening before use, cells were
seeded in appropriate tissue-culture dishes. For detection of PC-PLC ac-
tivity by the egg yolk gel overlay assay, 3.5–4 
 
3
 
 10
 
6
 
 J774 cells in 100-mm
tissue-culture dishes were infected with 4–8 
 
3
 
 10
 
7
 
 bacteria grown over-
night at 30
 
8
 
C, achieving an initial infection of approximately two to four
bacteria per cell. The cells were washed with PBS at 30 min after infection,
and gentamicin (50 
 
m
 
g/ml) was added at 1 h after infection. At 5.5 h after
infection, the cells were washed with PBS, lysed in 2
 
3
 
 SDS-PAGE sample
buffer, immediately frozen on dry ice, and then boiled for 5 min. The sam-
ples were resolved on a 10% SDS-polyacrylamide gel.
For [
 
35
 
S]methionine protein labeling, 10
 
6
 
 J774 cells in 35-mm tissue-cul-
ture dishes were infected with 5–10 
 
3
 
 10
 
6
 
 bacteria grown overnight at
30
 
8
 
C, achieving an initial infection of approximately one to two bacteria
per cell. At 30 min after infection, the cells were washed three times with
PBS, and methionine-free DME with 10% dialyzed FBS (Hyclone Labo-
ratories, Logan, UT) was added. Gentamicin (50 
 
m
 
g/ml) was added at 1 h
after infection. Cells were pulse labeled for 30 min at 4 h after infection
with 200 
 
m
 
l of the same medium containing gentamicin and 90 
 
m
 
Ci
[
 
35
 
S]methionine (Express 
 
35
 
S protein labeling mix; NEN
 
®
 
 Research Prod-
ucts, Boston, MA). In pulse-chase experiments, cells were pulse labeled
for 10 min, and then chased with unlabeled methionine (5 mM) and
chloramphenicol (20 
 
m
 
g/ml) to prevent further incorporation of labeled
methionine. Host cell protein synthesis was not blocked at any time. Bac-
terial counts were determined in triplicate for each strain in each experi-
ment as described previously (Portnoy et al., 1988). Samples were re-
solved on 11% SDS-polyacrylamide gels. The amount of sample loaded
per lane was normalized for the number of bacteria. After electrophoresis,
the gel was processed for fluorography (EN
 
3
 
HANCE; NEN
 
®
 
 Research
Products).
 
Inhibitor Studies
 
Inhibitors were present for 1 h before and during the 30-min pulse label-
ing. 
 
N
 
-acetyl-leucine-leucine-norleucine (LLnL), also called calpain inhib-
itor I, and 
 
N
 
-acetyl-leucine-leucine-methionine (LLM), also called calpain
inhibitor II, were obtained from Boehringer Mannheim Biochemicals (In-
dianapolis, IN). Benzyloxycarbonyl-phenylalanine-alanine-diazomethane
(Z-FA-CHN
 
2
 
) was obtained from Bachem Biochemicals (King of Prussia,
PA). A 25-mM solution of each inhibitor was prepared in methanol imme-
diately before use. Bafilomycin A
 
1
 
 was obtained from Sigma Chemical
Co. A 100-
 
m
 
M solution was prepared in DMSO and stored in a desiccator
at 
 
2
 
20
 
8
 
C. These inhibitors were used at concentrations indicated in the
text. An equal volume of methanol and/or DMSO was added to cells not
treated with inhibitors.
 
Affinity Purification of Antibody
 
The active form of PC-PLC was purified as described (Geoffroy et al.,
1991; Goldfine et al., 1993), and antiserum was raised in rabbits (Cocalico
Biologicals, Inc., Reamstown, PA). Specific PC-PLC antibodies were af-
finity purified (Olmsted, 1981), using the rabbit polyclonal antiserum and
purified PC-PLC protein. The purified protein (25–50 
 
m
 
g) was spotted di-
rectly on a small strip of polyvinylidene difluoride membrane and blocked
with 5% nonfat dry milk in TBS. The membrane was incubated with 1 ml
of the rabbit polyclonal immune serum for 2 h at 4
 
8
 
C, and then washed
four times in TBS-TX (TBS, 0.1% Triton X-100) and twice in TBS-EDTA
(TBS, 1 mM EDTA). Antibodies specific to PC-PLC were eluted twice in
1 ml of 0.2 M glycine-HCl, pH 3.0, at 4
 
8
 
C. After 2-min incubation times,
each aliquot was rapidly neutralized with 2 N NaOH. Aliquots were
pooled and diluted in 2 vol of PBS, 0.25% BSA, and 0.02% sodium azide.
The antibody solution was transferred into a Centriprep 10 concentrator
(Amicon, Inc., Beverly, MA) and centrifuged at 3,000 
 
g
 
 for 30 min at 4
 
8
 
C.
The final antibody solution was in a volume of 
 
z
 
1.2 ml. Each preparation
of affinity-purified antibodies was titrated to determine the optimal vol-
ume required for immunoprecipitation of PC-PLC from a lysate of 10
 
6
 
J774 cells infected with wild-type 
 
L. monocytogenes.
 
Immunoprecipitation of PC-PLC from Infected
J774 Cells
 
Immunoprecipitation was performed as previously described (Brundage
et al., 1993) with some modifications. Cell lysates and slurries of protein
A–Sepharose CL-4B beads (Sigma Chemical Co.) were prepared in RIPA
buffer (150 mM NaCl, 50 mM Tris-HCl, pH 8.0, 1% NP-40, 0.5% deoxy-
cholate, 0.1% SDS) supplemented with a cocktail of protease inhibitors
(Sigma Chemical Co.): 10 mM EDTA, 1 mM PMSF, 0.3 
 
m
 
M aprotinin,
1 
 
mM leupeptin, and 1 mM pepstatin. The affinity-purified antibody was
preadsorbed with a lysate of uninfected unlabeled cells (2 3 106) for 1 h at
48C. The volume of affinity-purified antibody used per reaction was deter-
mined as described above. The lysate of infected labeled cells (106) was
mixed with the adsorbed antibody for 1–1.5 h at 48C, and then with a
Table I. Bacterial Strains and Genotypes
Strain Genotype Source of strain or reference
10403S Wild-type Bishop and Hinrichs, 1987
DP-L1552 10403S DplcA Camilli et al., 1993
DP-L1935 10403S DplcB Smith et al., 1995
DP-L1936 10403S DplcA, DplcB Smith et al., 1995
DP-L1942 10403S DactA Brundage et al., 1993
DP-L2296 10403S Dmpl Marquis et al., 1995
DP-L2483 10403S DplcA, Dmpl This study
DP-L2484 DP-L2296 complemented with the wild-type mpl allele This study
DP-L2787 10403S DplcB, Dmpl This study
DP-L2869 10403S DplcA, DplcB, Dmpl This study
SLCC-5764 Hypersecreting wild-type isolate Camilli et al., 1993
DP-L1545 SLCC-5764 Dmpl This study
DP-L1553 SLCC-5764 DplcA Camilli et al., 1993
DP-L1938 SLCC-5764 DplcA, DplcB This study
DP-L1955 SLCC-5764 DactA This studyThe Journal of Cell Biology, Volume 137, 1997 1384
slurry of protein A–Sepharose beads (10 mg per lysate) for 1 h at 48C. Pro-
tein A beads were washed four times in the same buffer, and the immuno-
precipitates were recovered in 23 SDS sample buffer. The samples were
boiled for 5 min and stored at 2808C. Bacterial counts were determined in
parallel dishes, and equivalent numbers of bacteria were loaded per lane
of an 11% SDS-polyacrylamide gel.
Immunofluorescence
J774 cells (106) grown on 12-mm square coverslips in 35-mm dishes were
infected with 0.5–1 3 106 bacteria grown overnight at 308C, achieving an
initial infection of approximately one bacterium per 5 to 10 cells. At 5 h
after infection, infected cells were fixed with 3.3% formaldehyde EM-
Grade (Electron Microscopy Sciences, Ft. Washington, PA) in PBS and
permeabilized in TBS-TX. The samples were blocked with 1% BSA in
TBS-TX and all the antibodies were diluted in the same buffer. PC-PLC
was detected by reacting the samples successively with affinity-purified
rabbit anti–PC-PLC antibodies, donkey anti–rabbit IgG conjugated with
biotin (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA),
and rhodamine streptavidin (Molecular Probes, Eugene, OR). The lyso-
some-associated membrane protein 1 (Lamp1) was detected using a rat
mAb 1D4B (developed by J. Thomas August and obtained from the De-
velopmental Studies Hybridoma Bank, Iowa City, IA) and donkey anti–
rat conjugated with FITC (Jackson ImmunoResearch Laboratories, Inc.).
L. monocytogenes staining was performed last with a rabbit anti–L. mono-
cytogenes antibody conjugated with fluorescein (Difco Laboratories). Be-
tween each reaction, the coverslips were extensively washed with TBS-
TX. The coverslips were mounted with Testog FITC-Guard (Testog, Inc.,
Chicago, IL) and sealed on glass slides. Confocal microscopy was per-
formed using a TCS 4D apparatus (Leica Inc., Deerfield, IL) equipped
with an Image Graphics image recorder. (Focus Graphics Inc., Foster
City, CA). Selected fields were scanned with 0.07 mM pixel size and 0.5
mm step size. The intensity settings were constant for all samples tested
within each experiment.
Enzyme Assays
Two types of assays were performed to detect PC-PLC activity: an egg
yolk gel overlay assay (Kathariou et al., 1990) and an isotope-based assay
(Goldfine et al., 1993). For the egg yolk overlay assay, samples were
boiled and fractionated by SDS-PAGE. Immediately after electrophore-
sis, the gel was washed once in 25% isopropanol and twice in PBS (Ca21
and Mg21 free) for 30 min each time. The gel was then overlaid with egg
yolk soft agar (0.7% agarose, 2.5% egg yolk, 50 mM ZnCl2, 0.05 mM
CaCl2, 1 mM DTT, and 25 mg/ml gentamicin, in 13 PBS) and incubated at
378C. PC-PLC activity was detected by the formation of zones of opacity.
Periods of incubation varied from 2 h for the in vitro grown bacteria to 2 d
for the intracellularly grown bacteria.
The isotope-based enzyme assay was performed as described elsewhere
(Goldfine et al., 1993) with the exception that sodium deoxycholate (0.15%
final concentration) was used instead of Triton X-100 for the mixed mi-
celle suspension, and the concentration of PC and sphingomyelin was 0.15
mM. PC-PLC was immunoprecipitated from infected J774 cells as de-
scribed above with some modifications. J774 cells were not deprived of
methionine during infection and crude anti–PC-PLC rabbit hyperimmune
serum was used. The optimal concentration of crude antiserum was deter-
mined to be 1 ml. After immunoprecipitation, the pellets of protein A beads
were washed three times in RIPA buffer and once in 140 mM NaCl/10
mM Tris-HCl, pH 8.0. Enzyme assays were done directly in the microfuge
tubes (1.5 ml) containing the pellets of protein A beads to which PC-PLC–
antibody complexes were bound. Hydrolysis of [choline-methyl-3H]-phos-
phatidylcholine (3H-PC) and [choline-methyl-14C]-sphingomyelin (14C-
sphingomyelin) (NEN® Research Products) was measured as described
(Goldfine et al., 1993) after a 10-min incubation period at 378C. Under
these conditions, hydrolysis of PC was linear for at least 10 min and the
hydrolysis of sphingomyelin showed a lag of 2 to 5 min.
Results
Role of Mpl and the PLCs in Mouse Virulence and 
Plaque Formation
A series of deletions was generated into the PLC-, Mpl-,
and ActA-encoding genes to evaluate the requirements
for proPC-PLC proteolytic activation. The mutations were
introduced into the chromosome of L. monocytogenes
strains SLCC-5764 and 10403S. Proteolytic activation of
proPC-PLC was first evaluated in vitro, using SLCC-5764
and isogenic mutant strains. SLCC-5764 is a hypersecret-
ing strain of L. monocytogenes that facilitates in vitro anal-
ysis of virulence factors, such as ActA and PC-PLC, not
normally expressed in vitro (Camilli et al., 1993). ProPC-
PLC (Mr 33 kD) and the processed form of the enzyme
(Mr 28 kD) were identified by Coomassie blue staining
and Western immunoblotting. ProPC-PLC was secreted in
comparable amounts from each plcB positive strain (Fig.
1, a and b), indicating that the internal deletions in mpl
and actA genes, which are located within the same operon
and upstream of the plcB gene (Portnoy et al., 1992), did
not affect plcB gene expression. Similarly, the internal de-
letion in plcA, which is located within the same operon
and upstream of prfA, the transcriptional regulator encod-
ing gene (Portnoy et al., 1992), did not affect plcB gene ex-
pression (Fig. 1, a and b, lane 3). The processed form of
PC-PLC was secreted in comparable amounts from SLCC-
Figure 1. Detection of PC-PLC in the supernatant of L. monocy-
togenes broth cultures. Strain SLCC-5764 and isogenic mutants
were used for this experiment. For each assay, an equal volume
of concentrated bacterial secreted proteins was loaded per lane.
(a) Coomassie blue staining of secreted proteins resolved by
SDS-PAGE. (Lane 1) 31-kD protein marker; (lane 2) SLCC-
5764; (lane 3) DP-L1553 (PI-PLC2); (lane 4) DP-L1938 (PI-
PLC2, PC-PLC2); (lane 5) DP-L1955 (ActA2); (lane 6) DP-
L1545 (Mpl2). (b) Alkaline phosphatase Western immunoblot.
(Lane 1) 32-kD prestained molecular mass marker; (lanes 2–6)
same as in a. (c) Egg yolk gel overlay assay. (Lane 1) 32- and 42-kD
prestained molecular mass markers; (lanes 2–6) same as in a.Marquis et al. Activation and Degradation of Phospholipase C 1385
5764 and isogenic plcA and actA mutant strains (Fig. 1, a
and b, lanes 2, 3, and 5). Enzymatic activity, as determined
by the egg yolk gel overlay assay, comigrated with the pro-
cessed form of PC-PLC (compare Fig. 1 b to 1 c, lanes 2, 3,
and 5), confirming that PI-PLC and ActA are not required
for the proteolytic activation of proPC-PLC in vitro and
that the processed form is the active form of the enzyme.
A processed form of PC-PLC was detected in minute
amounts from the mpl mutant strain (Fig. 1, a and b, lane
6). However, there was no detectable PC-PLC activity as-
sociated with this mutant (Fig. 1 c, lane 6), even after in-
creasing the amount of protein loaded on the gel fourfold
(data not shown). This result is consistent with Mpl being
required for activation of proPC-PLC in broth culture as
previously reported (Poyart et al., 1993).
The virulence of wild-type strain 10403S and isogenic
mutants was evaluated in vivo using the mouse infection
model. The ability of these mutants to spread cell to cell
was evaluated in a mouse fibroblast cell line by a plaquing
assay. The results are reported in Fig. 2 and Table II. The
single plcA and plcB mutants show respective reductions
of 12% and 33% in plaque sizes, and the double plcA,
plcB mutant shows a reduction of 66% in plaque size. In
the mouse infection model, the plcA mutant shows a mi-
nor increase in LD50, the plcB mutant is 1 log less virulent,
whereas the double plcA, plcB mutant is 2.5 logs less viru-
lent than the wild-type strain. These results are consistent
with previously reported data, suggesting that the PLCs
have overlapping functions (Smith et al., 1995). The dou-
ble mpl, plcB mutant was phenotypically identical to the
single plcB mutant, consistent with Mpl function being re-
lated to the activation of proPC-PLC. Similarly, the triple
plcA, plcB, mpl mutant was phenotypically identical to the
double plcA, plcB mutant. A single mutation in the mpl
gene resulted in a 29% decrease in plaque size, also consis-
tent with Mpl being required for proPC-PLC activation.
However, the mpl mutant was as virulent as the wild-type
strain in the mouse infection model, which is inconsistent
with Mpl function being required for the activation of
proPC-PLC. In addition, a double plcA, mpl mutant had a
47% decrease in plaque size, which differs significantly (P ,
0.0001) from the 66% decrease observed with the double
plcA, plcB mutant. The double mpl, plcA mutant was z2
logs less virulent than wild type but not as attenuated as
the double plcA, plcB mutant in the mouse infection
model. Taken together, these data clearly show a role for
Mpl in bacterial cell-to-cell spread and reveal a role for
Mpl in virulence as seen in the double mpl, plcA mutant.
However, unlike the plcB mutant, the virulence of the sin-
gle mpl mutant was not attenuated in mice, and that of the
double mpl, plcA mutant was not as attenuated as the dou-
ble plcA, plcB mutant. These results raised the possibility
that intracellular activation of proPC-PLC may proceed in
the absence of Mpl.
Intracellular Activation of ProPC-PLC
To directly evaluate the role of Mpl in the intracellular ac-
Figure 2. Formation of
plaques in infected L2 mouse
fibroblasts. L2 cells were in-
fected with strain 10403S and
isogenic mutants. Cell mono-
layers were stained with neu-
tral red at 4 d after infection,
highlighting clear areas of
dead cells resulting from L.
monocytogenes intracellular
growth and cell-to-cell spread.
The mean plaque diameters
were calculated from several
individual experiments (see
Table II) and are indicated
below each well.
Table II. LD50s and Plaquing Results
Strain
LD50
in mice Plaque size
Source or
reference§
(CFU) %* 6 SD (n)‡
10403S 1–3 3 104 100 Portnoy et al., 1988
DP-L1552 3.2 3 104 88.3 6 6.0i (10) Camilli et al., 1993
DP-L1935 2 3 105 66.7 6 5.8i (18) Smith et al., 1995
DP-L2296 ,5 3 104 71.0 6 6.4 (17) This study
DP-L2787 3.5 3 105 66.4 6 4.3 (10) This study
DP-L1936 5 3 106 34.0 6 5.2i (15) Smith et al., 1995
DP-L2483 1.6 3 106 53.1 6 5.8 (16) This study
DP-L2869 ND 36.7 6 3.3 (5) This study
*Relative percentage of diameter of plaques formed in L2 cells by mutant strains in
comparison with the wild-type strain.
‡(n) 5 number of plaquing experiments.
§For LD50s’ data.
iPlaquing results from this study were combined with previously reported results from
this laboratory (Smith et al., 1995).The Journal of Cell Biology, Volume 137, 1997 1386
tivation of proPC-PLC, we examined the production and
processing of proPC-PLC in a tissue-culture model of in-
fection. At 4 h after infection, J774 cells were pulse labeled
for 30 min with [35S]methionine and lysed, and both forms
of PC-PLC were immunoprecipitated using affinity-puri-
fied antibodies. The precursor and processed forms of PC-
PLC were identified based on their relative migration on
SDS-PAGE, and by comparison with cells infected with
the plcB mutant strain. Both forms of the enzyme were
present in cells infected with either the wild-type strain or
the mpl mutant (Fig. 3, lanes 1 and 3), indicating that Mpl
was not essential for intracellular processing of proPC-
PLC. Furthermore, results from an egg yolk gel overlay as-
say from infected cells indicated that the processed form
of PC-PLC generated in cells infected with either the wild-
type strain or the mpl mutant had enzymatic activity (Fig.
4, lanes 2 and 5). Phospholipase activity was not detected
in uninfected cells or cells infected with the plcB mutant
(Fig. 4, lanes 1 and 3).
Subcellular Localization of PC-PLC
Double immunofluorescence staining and confocal micros-
copy was performed at 5 h after infection to determine the
site of PC-PLC and L. monocytogenes localization. Dis-
tinctively, only a small proportion of intracellular bacteria
stained positively for PC-PLC, and PC-PLC staining colo-
calized with L. monocytogenes (Fig. 5 A). The pattern of
PC-PLC staining suggested a vacuolar localization. Double
immunofluorescence staining of PC-PLC and Lamp1 was
performed to define more precisely the site of PC-PLC lo-
calization. Lamp1 is an endosomal/lysosomal marker
(Chen et al., 1985; Lewis et al., 1985) that increases in con-
centration with endosomal maturation (Berón et al., 1995;
Pitt et al., 1992). Colocalization of PC-PLC and Lamp1
was observed (Fig. 5, D and E), but the amount of Lamp1
colocalizing with PC-PLC varied considerably. This stain-
ing pattern suggested that PC-PLC was concentrated in
vacuoles that had fused with endosomes and lysosomes.
PC-PLC staining was not observed in filopodia-like struc-
tures, but we cannot eliminate the possibility that this
could be due to a lack of sensitivity of the technique used.
To directly address whether PC-PLC localized to sec-
ondary vacuoles formed upon bacterial cell-to-cell spread,
J774 cells were infected with a 10-fold lower multiplicity of
infection to facilitate identification of primary and second-
ary infected cells at 5 and 6 h after infection. Double im-
munofluorescence staining of PC-PLC and L. monocyto-
genes indicated that the majority of PC-PLC localized to
cells at the periphery of infected foci, presumably in sec-
ondary vacuoles formed during bacterial cell-to-cell spread.
An example of an infection focus at 6 h after infection is
shown in Fig. 5 B.
The Mpl-dependent and -independent Pathways of 
ProPC-PLC Proteolytic Activation
The above results suggested that secondary vacuoles formed
during bacterial cell-to-cell spread fused with vesicles of
the endocytic pathway (Berón et al., 1995; Gruenberg and
Maxfield, 1995; Pitt et al., 1992). To assess the role of vacu-
olar acidification and lysosomal enzymes in proPC-PLC pro-
cessing, we used two enzyme inhibitors. The first, bafilomy-
cin A1, is a specific inhibitor of the vacuolar proton pump
ATPase (Yoshimori et al., 1991), which serves to acidify a
vacuolar compartment. The second is a peptidyldiazomethane,
Z-FA-CHN2, which specifically inactivates cysteine pro-
teases by alkylation of the reactive site cysteine residue
(Leary et al., 1977). Z-FA-CHN2 has strong affinity for
cathepsins B and L (Crawford et al., 1988; Kirschke and
Shaw, 1981; Wilcox and Mason, 1992), which are lysoso-
mal acid cysteine proteases, but does not react with the
calpains (Crawford et al., 1988), which are cytosolic cal-
cium-activated neutral cysteine proteases. The results
showed that both bafilomycin A1 and Z-FA-CHN2
blocked processing of proPC-PLC in cells infected with the
mpl mutant (Fig. 6, lanes 5 and 6). In wild-type infected
cells, processing of proPC-PLC was not affected by Z-FA-
CHN2, but no processing was detected in cells treated with
bafilomycin A1 (Fig. 6, lanes 2 and 3), although the protein
was detected by immunofluorescence in secondary vacu-
oles (data not shown). Neither bafilomycin A1 nor Z-FA-
CHN2 inhibited activation of proPC-PLC in broth culture
(data not shown). These results indicate that there are two
intracellular pathways of activation of proPC-PLC: an
Mpl-mediated pathway and a cysteine protease-mediated
Figure 3. Detection of PC-PLC from lysates of infected cells.
J774 cells were infected with strain 10403S and isogenic mutants.
At 4 h after infection, cells were pulse labeled for 30 min with
[35S]methionine. Immediately after the pulse, the cells were lysed,
PC-PLC was immunoprecipitated using affinity-purified antibod-
ies, and proteins were fractionated by SDS-PAGE. PC-PLC was
detected by fluorography. (Lane 1) 10403S; (lane 2) DP-L1935
(PC-PLC2); (lane 3) DP-L2296 (Mpl2). Number of colony form-
ing units (CFU) per sample: 2.8 3 107 (lanes 1 and 3), and 2.6 3
107 (lane 2).
Figure 4. PC-PLC activity in lysates of infected cells. J774 cells
were infected with strain 10403S and isogenic mutants. Cells were
harvested in 23 SDS sample buffer at 5.5 h after infection. After
electrophoresis, the gel was successively soaked in isopropanol
and PBS and overlaid with egg yolk agar. Zones of opacity are in-
dicative of phospholipase activity. (Lane 1) Uninfected cells;
(lane 2) 10403S; (lane 3) DP-L1935 (PC-PLC2); (lane 4) DP-
L1942 (ActA2); (lane 5) DP-L2296 (Mpl2). Number of CFU per
sample: 1.5 3 108 (lane 2), 2.0 3 108 (lane 3), 2.7 3 108 (lane 4),
and 1.9 3 108 (lane 5).Marquis et al. Activation and Degradation of Phospholipase C 1387
pathway. Both pathways were blocked by a specific inhibi-
tor of the vacuolar proton pump ATPase, suggesting that
vacuolar acidification is a prerequisite to the intracellular
processing of proPC-PLC.
Intracellular Activity of PC-PLC on 
Phosphatidylcholine and Sphingomyelin
Intracellular activation of proPC-PLC was mediated by ei-
Figure 5. Immunolocalization of PC-PLC in infected cells. J774 cells were infected with strain 10403S (A, B, and D), or isogenic mutants
DP-L1935 (PC-PLC2) (C) and DP-L2296 (Mpl2) (E). Cells were fixed in formalin at either 5 (A and C–E) or 6 h after infection (B),
stained for immunofluorescence analysis as described in Materials and Methods, and analyzed by confocal microscopy (0.5-mm sec-
tions). (A–E) PC-PLC (rhodamine); (A–C) L. monocytogenes (fluorescein); (D and E) Lamp1 (fluorescein). Overlapping of both fluors
(rhodamine and fluorescein) generates yellow. (A, arrows) Examples of bacteria/PC-PLC colocalized staining suggesting vacuolar local-
ization; (arrowheads) PC-PLC staining at the septum of dividing bacteria. (B) In this experiment, cells were infected with 10-fold less
bacteria to facilitate identification of primary (highly infected central cell) and secondary infected cells (peripheral cells). The back-
ground of this particular field was increased by computer to facilitate visualization of the cells. (Arrows) Examples of bacteria/PC-PLC
colocalizing in three different secondary infected cells. (D and E) Large arrows show examples of PC-PLC–containing vacuoles with no
Lamp1 staining, whereas small arrows show examples suggesting advanced fusion events between PC-PLC–containing vacuoles and
Lamp1-positive endosomes. Arrowhead at the bottom of D shows a PC-PLC–containing vacuole surrounded by Lamp1. Bars, 10 mm.The Journal of Cell Biology, Volume 137, 1997 1388
ther Mpl or a cysteine protease, raising the possibility that
PC-PLC activity might vary depending on the activating
protease. To address that point, we investigated the activi-
ties of PC-PLC generated in cells infected with either the
wild-type strain or the mpl mutant. PC-PLC was immuno-
precipitated from infected cells, and the enzymatic assay
was performed directly on PC-PLC bound to antibodies
on protein A–Sepharose beads. Hydrolysis of 3H-PC and
14C-sphingomyelin by immunoprecipitated PC-PLC was
measured as described in Materials and Methods. In either
case, PC-PLC was capable of mediating PC and sphingo-
myelin hydrolysis (Table III). When corrected for the
number of bacteria per dish, the ability of PC-PLC gener-
ated by the wild-type strain and the mpl mutant to hydro-
lyze PC and sphingomyelin was essentially the same, al-
though a small shift in substrate preference was observed.
Phospholipase activity was not detected on immunopre-
cipitates from uninfected cells or cells infected with the
plcB mutant (data not shown).
Proteolytic Activation of ProPC-PLC in the Absence of 
Bacterial Cell-to-Cell Spread
The above results indicated that PC-PLC localized to
Lamp1-positive vacuoles (Fig. 5) and that vacuolar acidifi-
cation was a prerequisite to proPC-PLC activation (Fig. 6,
lanes 2 and 5). These results suggested that active PC-PLC
would not be generated in the cytosol of infected cells. To
further investigate the intracellular requirements for proPC-
PLC activation, we monitored the presence of PC-PLC in
cells infected with an actA mutant of L. monocytogenes
that is defective in actin-based motility, and consequently
fails to spread cell to cell. ProPC-PLC was immunoprecip-
itated in similar amounts in cells infected with either the
wild-type strain or the actA mutant, indicating that proPC-
PLC was synthesized by cytosolic bacteria, but processing
of proPC-PLC, although observable, was very inefficient
in the cytosol of cells infected with the actA mutant (Fig. 7,
compare lanes 1 and 5).
To eliminate the possibility that ActA was directly in-
volved in proPC-PLC processing, we infected cells with
the wild-type strain, and then blocked bacterial cell-to-cell
spread by adding cytochalasin D (Dabiri et al., 1990; Til-
ney and Portnoy, 1989), an inhibitor of actin polymeriza-
tion, 30 min before labeling. Again, the precursor form of
PC-PLC was present in these infected cells but the pro-
cessed form was not detectable, indicating that ActA was
not directly responsible for proPC-PLC processing (Fig. 7,
lane 4). Moreover, the amount of processed PC-PLC was
largely reduced when actin polymerization was blocked as
late as 10 min into the pulse, and it was barely detectable
when actin polymerization was blocked 10 min before la-
beling (Fig. 7, lanes 2 and 3). Results from the cytochalasin
D time course experiment indicated that continuous bac-
terial spreading was required for proPC-PLC processing.
Not surprisingly, PC-PLC activity, as measured by the egg
yolk gel overlay assay, was detected neither in cells in-
fected with the actA mutant strain (Fig. 4, lane 4) nor in
wild-type infected cells treated with cytochalasin D (data
not shown). Therefore, proPC-PLC proteolytic activation,
but not synthesis, occurred predominantly in secondary
vacuoles.
Cytosolic Degradation of ProPC-PLC
Our observations indicated that proPC-PLC proteolytic
activation was inefficient in the absence of bacterial cell-
to-cell spread (Fig. 7). However, in the absence of pro-
teolytic activation, proPC-PLC did not appear to accumulate
intracellularly, suggesting that proPC-PLC was rapidly de-
Figure 6. The effect of bafilomycin A1 and Z-FA-CHN2 on
proPC-PLC processing in infected cells. J774 cells were infected
with strain 10403S and isogenic mutants. At 4 h after infection,
cells were processed as described in legend of Fig. 3. Bafilomycin
A1 (Baf) (lanes 2 and 5) or Z-FA-CHN2 (Z-FA) (lanes 3 and 6)
was added at 3 h after infection at final concentrations of 1 mM
and 10 mM, respectively. The inhibitors were also present during
pulse labeling. (Lanes 1–3) 10403S; (lanes 4–6) DP-L2296
(Mpl2); (lane 7) DP-L1935 (PC-PLC2). Number of CFU per
sample was 3.9 3 107.
Table III. Phospholipase Activities of Immunoprecipitated
PC-PLC from Cells Infected with Either Wild-Type Strain or 
the mpl Mutant
Strain
PC-PLC activity
on PC: nmol/
10 min/108
CFU (n)*
PC-PLC activity
on sphingomyelin:
nmol/10 min/108
CFU (n)*
Relative activity
sphingomyelin/PC
(n)*
10403S 1.00 6 0.58 (4) 0.091 6 0.052 (5) 0.095 6 0.018 (4)
DP-L2296 1.32 6 0.82‡ (5) 0.098 6 0.075‡ (5) 0.068 6 0.011§ (5)
*(n) 5 number of experiments.
‡P . 0.05 by unpaired t test (NS).
§P , 0.05 by unpaired t test (significant).
Figure 7. Detection of PC-PLC from lysates of cells infected with
nonspreading bacteria. J774 cells were infected with strain 10403S
and isogenic mutants. At 4 h after infection, cells were processed
as described in legend of Fig. 3. Cytochalasin D was added at
times relative to the beginning of labeling (as indicated on the fig-
ure) and during labeling at a final concentration of 1 mM (lanes
2–4). (Lanes 1–4) 10403S; (lane 5) DP-L1942 (ActA2); (lane 6)
DP-L1935 (PC-PLC2). Number of CFU per sample was 1.9 3 107
for lanes 1–4, 1.3 3 107 for lane 5, and 2.2 3 107 for lane 6.Marquis et al. Activation and Degradation of Phospholipase C 1389
graded when secreted in the cytosol of the host cell. Pro-
teolytic degradation of cytosolic proteins is mostly protea-
some dependent (Rock et al., 1994). We investigated the
role of the proteasome in the intracellular degradation of
proPC-PLC using two aldehyde tripeptide inhibitors: LLnL
and LLM. LLnL blocks the proteasome activity, while LLM
does not (Rock et al., 1994; Vinitsky et al., 1992).
The intracellular stability of proPC-PLC was evaluated
by a pulse-chase experiment. Cells infected with ActA2
bacteria were treated with either LLnL or LLM at 3 h af-
ter infection and the inhibitors were present during the en-
tire pulse-chase experiment. At 3 h and 50 min after infec-
tion, cells were pulse labeled with [35S]methionine for 10
min, and then chased for specific periods of time. A role
for the proteasome in proPC-PLC degradation was dem-
onstrated by the observation that proPC-PLC was stabi-
lized in infected cells treated with LLnL (Fig. 8, compare
lanes 5–8 to lanes 1–4), but not in those treated with LLM
(Fig. 8, lanes 9–12). Indeed, the half-life of proPC-PLC was
,15 min in either untreated or LLM-treated cells, and
.60 min in LLnL-treated cells. The intracellular stability
of proPC-PLC was comparable in cells infected with either
the wild-type strain, the mpl mutant, or the actA mutant
(data not shown). Yet, in wild-type and Mpl2 infected cells,
proPC-PLC chased into active PC-PLC (data not shown).
These results suggested an additional level of PC-PLC reg-
ulation by proteolytic degradation of the precursor.
ProPC-PLC secreted into the cytosol was degraded by
host proteases and consequently had a short half-life.
Discussion
L. monocytogenes has the remarkable ability to spread
from one cell to another without exposure to the extracel-
lular environment. The currently accepted model proposes
that  L. monocytogenes exploits a host system of actin-
based motility to move into cellular projections that are in-
ternalized by neighboring cells, resulting in bacteria tran-
siently confined within double membrane vacuoles (Tilney
and Portnoy, 1989). The molecular and cellular mecha-
nisms that govern bacterial cell-to-cell spread are not yet
understood. However, in this and other studies, three L.
monocytogenes secreted polypeptides have been identified
that mediate bacterial cell-to-cell spread. Two of these
polypeptides are phospholipases of the C class: PI-PLC
and PC-PLC (Smith et al., 1995; Vazquez-Boland et al.,
1992). PC-PLC is secreted as an inactive precursor (proPC-
PLC), which is proteolytically activated by a third L.
monocytogenes secreted product, a metalloprotease (Mpl)
(Poyart et al., 1993). In this study we show that there are
three potential fates for proPC-PLC subsequent to secre-
tion by intracellular L. monocytogenes. In the absence of
bacterial cell-to-cell spread, proPC-PLC secreted in the
host cytosol was rapidly degraded in a proteasome-depen-
dent manner. During bacterial cell-to-cell spread, proPC-
PLC activation was mediated by either Mpl or a cysteine
protease presumably of host origin. The majority of PC-
PLC staining was found in Lamp1-positive vacuoles. Lastly,
proPC-PLC activation by either pathway was blocked by
bafilomycin A1, a specific inhibitor of the vacuolar proton
pump ATPase.
It was previously shown that Mpl is responsible for me-
diating proPC-PLC activation during growth in liquid me-
dium (Poyart et al., 1993). Based on this observation, we
hypothesized that Mpl was responsible for mediating in-
tracellular activation of proPC-PLC. The results of this
study clearly show that Mpl is not essential for the pro-
teolytic activation of proPC-PLC during infection, as the
active form of PC-PLC was detected in cells infected with
the mpl mutant. The Mpl-independent pathway of proPC-
PLC activation was blocked with an inhibitor of cysteine
proteases. However, this inhibitor did not block proPC-
PLC activation in cells infected with the wild-type strain.
These results are consistent with the existence of two in-
tracellular pathways of proPC-PLC activation: an Mpl-
mediated pathway and a cysteine protease-mediated path-
way. The presence of an Mpl-independent pathway is also
consistent with our genetic data in which an mpl mutant
had a different phenotype than a plcB mutant. Lastly, these
results do not exclude the possibility that Mpl has another
role than proPC-PLC activation.
Two different classes of proteases, a metalloprotease
and a cysteine protease, were capable of mediating proPC-
PLC activation. We considered the possibility that the two
activating proteases might have different cleavage recog-
nition sites, resulting in altered PC-PLC activity. Our re-
sults revealed retention of PC and sphingomyelin hydro-
lytic capacity by the host-processed enzyme, with a small
shift in substrate preference. Therefore, if there was a dif-
ference in cleavage recognition sites, the consequences for
PC-PLC enzymatic activity were minor. We also need to
consider the possibility that Mpl-mediated activation of
proPC-PLC occurs earlier than Mpl-independent activa-
tion of proPC-PLC, with the bacterial protease acting
upon secretion, and the cysteine protease acting after se-
cretion. The consequence would be Mpl-mediated activa-
tion of proPC-PLC in a different cellular compartment
than the cysteine protease-mediated activation. In mice,
L. monocytogenes probably spreads from macrophages to
hepatocytes and from hepatocyte to hepatocyte (North,
1970; Rosen et al., 1989). The importance of the cysteine
protease pathway in the intracellular activation of proPC-
PLC may vary among cell types.
Immunofluorescence studies revealed that PC-PLC was
concentrated in host cell vacuoles which contained L.
Figure 8. Determination of proPC-PLC intracellular stability in
cells infected with nonspreading bacteria. J774 cells were infected
with 10403S isogenic mutants. Cells were pulse labeled for 10 min
with [35S]methionine at 3 h and 50 min after infection, and then
chased with methionine and chloramphenicol to prevent further
incorporation of labeled methionine. Host protease inhibitors
were added 1 h before labeling and during labeling at a final con-
centration of 50 mM. Samples were harvested for PC-PLC immu-
noprecipitation at specific times during the chase. PC-PLC was
detected by fluorography. (Lanes 1–12) DP-L1942 (ActA2);
(lane  13) DP-L1935 (PC-PLC2). Number of CFU per sample was
1.4 3 107.The Journal of Cell Biology, Volume 137, 1997 1390
monocytogenes. Based on our current model (Tilney and
Portnoy, 1989), we propose that these vacuoles are formed
during bacterial cell-to-cell spread. The observation that
these vacuoles stained positive for Lamp1 indicates that
they fused with vesicles of the endocytic pathway (Berón
et al., 1995; Gruenberg and Maxfield, 1995; Pitt et al.,
1992). This is consistent with proPC-PLC activation being
mediated by the lysosomal proteases, cathepsins B and L,
in cells infected with the mpl mutant. This is also consis-
tent with proPC-PLC activation being dependent on vacu-
olar acidification as the cathepsins are acid hydrolases
(Bohley and Seglen, 1992). However, it was surprising that
vacuolar acidification was a prerequisite for the Mpl-medi-
ated activation of proPC-PLC. Presumably, Mpl is se-
creted as a proenzyme that becomes activated by autocat-
alytic processing as demonstrated for homologous bacterial
metalloproteases (Mengaud et al., 1991; Häse and Finkel-
stein, 1993). Perhaps, Mpl activation and/or catalytic activ-
ity are pH dependent. Alternatively, proPC-PLC may be
more susceptible to proteolytic activation when secreted
in the acidic vacuolar environment. Another possibility is
that bafilomycin A1 blocks the action of the pore-forming
protein, LLO, which is known to have an acidic pH opti-
mum (Geoffroy et al., 1987). Perhaps, LLO-induced pore
formation is a prerequisite for Mpl and/or proPC-PLC ex-
pression. Unfortunately, we are unable to directly assess
the role of LLO because LLO2 mutants fail to escape
from the primary vacuole, and thus fail to grow (Gaillard
et al., 1987; Tilney and Portnoy, 1989). Interestingly, ba-
filomycin A1 blocks L. monocytogenes escape from the
primary vacuole in Caco-2 cells, a human carcinoma cell
line (Conte et al., 1996). Lastly, bafilomycin A1 blocks
acidification of the vacuole (Yoshimori et al., 1991) and
endosomal maturation (Clague et al., 1994; van Weert et
al., 1995). Perhaps additional host factors are required for
proPC-PLC activation. Based on these observations, we
propose that conventional vacuolar maturation (Berón et
al., 1995; Desjardins et al., 1994; Gruenberg and Maxfield,
1995) occurs before bacterial escape from the secondary
vacuole, and we speculate that the activation of proPC-
PLC by either Mpl or the cysteine protease depends on
the stage of maturation of the phagosome.
In the absence of bacterial cell-to-cell spread, proPC-
PLC was still synthesized but was rapidly degraded with a
half-life of ,15 min. Degradation of proPC-PLC was
blocked by an inhibitor of the host proteasome, which is
the major cytosolic proteolytic system of eukaryotic cells
(Rock et al., 1994). There is precedent for this finding in
that the L. monocytogenes hemolysin is also released into
the cytosol and degraded in a proteasome-dependent
manner (Villanueva et al., 1995). Interestingly, even when
the degradation of proPC-PLC was prevented, no mature
PC-PLC appeared. Thus, there are two mechanisms to
prevent PC-PLC production in the cytosol: degradation
and lack of activation. Hence, active PC-PLC is restricted
to a vacuolar compartment. These observations are consis-
tent with previous results showing that sustained elevation
of ceramide, a product of sphingomyelin hydrolysis, was
observed in cells infected with the wild-type strain but not
in cells infected with the actA mutant (Smith et al., 1995).
Intracellular parasites by necessity use host processes
for the regulation of pathogenesis. The results of this study
define two potential levels of regulation that are depen-
dent on bacterial subcellular localization (Fig. 9). The first
level of regulation is proteolytic activation. ProPC-PLC
secreted in vacuoles is activated by either a bacterial or a
host protease subsequent to acidification of the vacuole.
The second level of regulation is proteolytic degradation.
ProPC-PLC secreted into the cytosol is degraded by host
proteases, and consequently has a short half-life and is es-
sentially inactive in the cytosol. The results presented in
this study are the first to demonstrate proteolytic regula-
tion of a product secreted intracellularly by a bacterial
pathogen.
Figure 9. Schematic representation of the intracellular regulation
of proPC-PLC activity. Asymmetric polymerization of host actin
at the bacterial surface results in actin-based motility, which facil-
itates direct bacterial cell-to-cell spread. During cell-to-cell
spread, the bacterium becomes transiently trapped in a double
membrane vacuole, which fuses with Lamp1-positive vesicles.
ProPC-PLC secreted in the vacuole is activated by either a bacte-
rial or a host protease subsequent to acidification of the vacuole.
Upon lysis of the vacuole, which is mediated in part by the phos-
pholipases, the bacterium gains access to the cytosol where se-
creted proPC-PLC is degraded by the proteasome.Marquis et al. Activation and Degradation of Phospholipase C 1391
In conclusion, it appears that much of the regulation of
L. monocytogenes pathogenesis occurs at levels subse-
quent to secretion. Regulatory proteolysis and pH require-
ments of L. monocytogenes virulence factors facilitate bac-
terial cell-to-cell spread with minimal damage to the host
cell. We recently proposed that cytosolic half-life and pH
optimum are factors preventing LLO cytotoxicity (Jones
et al., 1996). The present study emphasizes the importance
of host-mediated posttranslational control in the patho-
genesis of intracellular parasites.
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